← All candidates
Five insider buys in the last year — $89.6K in all.
34 filings on record.
STROSUTRO BIOPHARMA, INC.
NasdaqGM · Healthcare · $279.56M
$16.86
-5.44% · Sep 11
Five insider buys in the last year — $89.6K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 5 buys◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$279.56M
Float
10.8M
65% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
6.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Matsui Connie
Bought $40.0K on Oct 15 — 50,000 sh @ $0.7990, held direct, 100% of their stake.
1 of 1 position beat the S&P
CFO
Chow Gregory K.
Bought $16.0K on Oct 15 — 19,750 sh @ $0.8100, held direct, 100% of their stake.
1 of 1 position beat the S&P
CHIEF SCIENTIFIC OFFICER
Gerber Hans-Peter
Bought $13.6K on Oct 15 — 17,000 sh @ $0.8004, held direct, 24% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
22 more transactions on Pro →The file stays open
34 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice